Acute tumour lysis syndrome with extreme metabolic abnormalities

Y. LEONOV, A. GOLIK, S. KAUFMAN, Y. GILBOA

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Summary Tumour lysis syndrome, manifested by various metabolic derangements, is a known complication after treatment of some lymphoid malignancies. A patient is reported with acute lymphocytic leukaemia who developed a tumour lysis syndrome following intensive chemotherapy. All the known complications of the syndrome were present in the most severe form—hyperuricaemia of 1.44 mmol/l, hyperphosphataemia of 7.7 mmol/l with acute oliguric renal failure and extreme hyperkalaemia of 9.8 mmol/l with electrocardiographic changes. This life‐threatening condition did not respond to conservative measures and the patient recovered only after haemodialysis.

Original languageEnglish
Pages (from-to)85-89
Number of pages5
JournalInternational Journal of Laboratory Hematology
Volume9
Issue number1
DOIs
StatePublished - Mar 1987
Externally publishedYes

Keywords

  • haemodialysis
  • hyperkalaemia
  • hyperphosphataemia
  • hyperuricaemia
  • tumour lysis syndrome

Fingerprint

Dive into the research topics of 'Acute tumour lysis syndrome with extreme metabolic abnormalities'. Together they form a unique fingerprint.

Cite this